News

Aphex BioCleanse Systems, Inc. (OTCPK: SNST) ("Aphex" or the "Company"), a sanitization solutions company focused on the development and distribution of chemical-free, water-based sanitization and disinfection products trademarked as Hy-IQ® Water, announced today they have filed required financial and disclosure reports with the OTC Pink reporting service for the quarter ending September 30, 2020.

Aphex BioCleanse Systems, Inc. (OTCPK: SNST) ("Aphex" or "the Company"), a sanitization solutions company focused on the development and distribution of chemical-free, water-based sanitization and disinfection products trademarked as Hy-IQ® Water, announced today that seasoned sports and business marketing executive Mark Washo has joined the Company as Senior Vice President of Sales and Marketing.

Aphex BioCleanse Systems, Inc. (OTCPK: SNST) ("Aphex" or "the Company"), a sanitization solutions company focused on the development and distribution of chemical-free, water-based sanitization and disinfection products trademarked as Hy-IQ® Water, has implemented Oracle NetSuite to streamline business operations and create a platform for sustainable growth. With NetSuite, Aphex will continue to scale its operations to support the increased demand for chemical-free, water-based sanitization and disinfecting products.

Aphex BioCleanse Systems, Inc. (OTCPK: SNST) ("Aphex" or "the Company"), a sanitization solutions company focused on the development and distribution of chemical-free, water-based sanitization and disinfection products trademarked as Hy-IQ® Water, announced today that internationally recognized businessman, veteran entrepreneur and original Shark Tank investor Kevin Harrington and his "Mentor to Millions" co-author Mark Timm have joined the Company as advisors.

Aphex BioCleanse Systems, Inc. (OTC: SNST) ("Aphex" or "the Company"), a sanitization solutions company focused on the development and distribution of chemical-free, water-based sanitization and disinfection products, announced today that it is celebrating the six month anniversary of study results revealing that its proprietary Hy-IQ® Water formula effectively neutralizes Candida auris.

Aphex BioCleanse Systems, Inc. (OTC: SNST) ("Aphex" or "the Company"), a sanitization solutions company focused on the development and distribution of chemical-free, water-based sanitization and disinfection products, announced today that the Company has appointed CMW Media, a creative and public relations agency specializing in emerging markets, as its strategic communications firm.

Aphex BioCleanse Systems, Inc. (OTC: SNST) ("Aphex" or "the Company"), a sanitization solutions company focused on the development and distribution of chemical-free, water-based sanitization and disinfection products, announced today that the Company has appointed Hancock Askew & Co., LLP ("Hancock Askew"), a full-service audit, tax, accounting and advisory firm, as its new PCAOB-qualified auditor and has hired an accounting consultant to augment its internal accounting staff.

Aphex BioCleanse Systems, Inc. (OTC: SNST) ("Aphex" or "the Company"), a sanitization solutions company focused on the development and distribution of chemical-free, water-based sanitization and disinfection products, announced today that the Company has entered into an agreement with Now Biopharma to conduct a hand sanitizer clinical trial in accordance with Federal Register Document No. RIN0910, Safety and Efficacy of Health Care Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use. Final Rule (Dec. 20, 2017).

Aphex BioCleanse Systems Inc. (OTC: SNST) announces today that the Company is continuing the buildout and expanding production of its revolutionary non-alcohol, non-toxic hydrogen based germ killing formula Hy-IQ™ at its Port Richey Florida facility. The buildout design has been completed and General Contracting work will commence in the near future.

Aphex BioCleanse Systems Inc. (OTC-SNST) announces today that the Company has received the filed and Completed Satisfactions of two Judicial Liens totaling $7,837,875 plus accruing statutory interest that remained on the Sunset Capital Assets Inc Balance Sheet.  Effective July 31, 2020 and as previously reported on August 2, 2020, Sunset Capital Assets has acquired Aphex BioCleanse Systems and will operate as Aphex on a forward going basis.

Anthony Betros was the wrong nameJACKSONVILLE, FL / ACCESSWIRE / August 3, 2020 / Sunset Capital Assets Inc.

JACKSONVILLE, FL / ACCESSWIRE / August 3, 2020 / Sunset Capital Assets Inc.

JACKSONVILLE, FL / ACCESSWIRE / July 14, 2020 / Sunset Capital Assets, Inc. ("Sunset" or the "Company") (OTC PINK:SNST) is announcing that it has amended its articles of incorporation to increase the Company's total authorized common shares from 50,000,000 to 750,000,000. The Company has also filed a Certificate of Designation for the Company's existing Series A Preferred Shares. Sunset Capital Assets, Inc. operates as a boutique, global, investment and advisory firm headquartered in Jacksonville, FL and founded in 2012.